Brief: Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox Announced
Dec 10 (Reuters) - SIGA Technologies Inc SIGA.O :
* INTERIM RESULTS FROM STOMP STUDY OF SIGA’S TECOVIRIMAT IN
TREATMENT OF MPOX ANNOUNCED
* SIGA TECHNOLOGIES INC - STUDY STOPPED ENROLLING PATIENTS
IN ALL
STUDY ARMS
* SIGA TECHNOLOGIES INC - EFFICACY IN SEVERE MPOX PATIENTS
NOT
ASSESSED IN STUDY
Source text: urn:newsml:reuters.com:*:nGNX9ZNHlH
Further company coverage: SIGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SIGA Technologies
See all newsBrief: Siga Secures Contract Valued At Up To $15 Million From Canadian Department Of National Defence To Purchase Tpoxx®
SIGA Technologies Q2 revenue, profit drop as contract ends
SIGA Technologies Q1 revenue falls, net loss widens
Brief: SIGA Technologies Q1 EPS USD -0.05
Brief: EMA Recommends Restricting Use Of Tecovirimat SIGA